The study aimed at evaluating the integration into everyday care of an electronic health solution, (I-eHealth). In non biological therapies, patients ages 10 to 17 were offered the I-eHealth solution for inflammatory bowel diseases (IBDs). The request was used every month and for flare-ups. Every 3 months and throughout the course of inflammations, blood and faecal calprotectin (FC) were analysed. The patient was depicted with a traffic light curve as a total inflammatory score. Depending on the total inflammation on demand, visits were organised. I-eHealth results have been compared to data from a prior RCT-eHealth Study. I-eHealth followed 36 IBD patients, average age of 14.7 years. The median time of use of I-eHealth was 1.9 years equivalent to 66.11, in the RCT-eHealth group it was 40.45 and in the RCT-control group it was 46.49. The patient-year on-demand visits did not vary between groups: 1.13, 1.16 and 0.84. The groups of hospitalisation and acute ambulatory hospital visits did not differ: 0.11 and 0.11, 0.05 and 0.02, 0.11 and 0.11 per patient-year.

There was no difference between the I-eHealth Group and the data from the clinical study after first escalation of the medicine and on-demand visits. In RCT supervision, eHealth is comparable to eHealth findings.